The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome

Not Applicable

Recruiting

• Conditions: Portal vein thrombosis or Budd-Chiari syndrome

• Registration Number: JPRN-UMIN000015319
• Lead Sponsor: Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-10-12
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1) patients with Child-Pugh classification C 2) patients with severe cardiac or pulmonary dysfunction 3) patients with hemoglobin A1c > 6.5 4) patients with treatment history of dabigatran 5) patients who need treatment of dabigatran combined with other anticoagulant or antiplatelet agent 6) patients with creatinine clearance < 50 ml/min 7) patients who have bleeding symptom or hemophliac 8) patients with peptic ulcers 9) patients with history of cerebral bleeding within 6 months 10) patients with epidural catheter 11) patients with use of non-steroidal anti-inflammatory drugs 12) patients with use of P-glycoprotein repressor 13) patients with use of itoraconazole 14) patients using cardiac pacemaker 15) pregnant woman

Study & Design

• Study Type: Interventional,observational
• Study Design: Not specified